[go: up one dir, main page]

ZA200109089B - Fast-dispersing dosage forms containing fish gelatin. - Google Patents

Fast-dispersing dosage forms containing fish gelatin.

Info

Publication number
ZA200109089B
ZA200109089B ZA200109089A ZA200109089A ZA200109089B ZA 200109089 B ZA200109089 B ZA 200109089B ZA 200109089 A ZA200109089 A ZA 200109089A ZA 200109089 A ZA200109089 A ZA 200109089A ZA 200109089 B ZA200109089 B ZA 200109089B
Authority
ZA
South Africa
Prior art keywords
fast
fish gelatin
dispersing dosage
composition
dosage forms
Prior art date
Application number
ZA200109089A
Other languages
English (en)
Inventor
Owen Murray
Richard Green
Michael Hall
Patrick Kearney
Original Assignee
Scherer Corp R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Corp R P filed Critical Scherer Corp R P
Publication of ZA200109089B publication Critical patent/ZA200109089B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200109089A 1999-04-08 2001-11-02 Fast-dispersing dosage forms containing fish gelatin. ZA200109089B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9908014.5A GB9908014D0 (en) 1999-04-08 1999-04-08 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA200109089B true ZA200109089B (en) 2003-04-30

Family

ID=10851154

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200109089A ZA200109089B (en) 1999-04-08 2001-11-02 Fast-dispersing dosage forms containing fish gelatin.

Country Status (28)

Country Link
US (2) US6709669B1 (xx)
EP (1) EP1165053B1 (xx)
JP (1) JP4838939B2 (xx)
KR (1) KR100767076B1 (xx)
CN (1) CN1224381C (xx)
AT (1) ATE262890T1 (xx)
AU (1) AU761439B2 (xx)
BR (1) BR0009609A (xx)
CA (1) CA2369715C (xx)
CZ (1) CZ295324B6 (xx)
DE (1) DE60009472T2 (xx)
DK (1) DK1165053T3 (xx)
ES (1) ES2215645T3 (xx)
GB (1) GB9908014D0 (xx)
HK (1) HK1039066B (xx)
HU (1) HU229892B1 (xx)
IL (2) IL145783A0 (xx)
IS (1) IS2403B (xx)
MX (1) MXPA01010094A (xx)
NO (1) NO330196B1 (xx)
NZ (1) NZ515230A (xx)
PL (1) PL196572B1 (xx)
PT (1) PT1165053E (xx)
RO (1) RO122011B1 (xx)
RU (1) RU2242969C2 (xx)
TR (1) TR200102881T2 (xx)
WO (1) WO2000061117A1 (xx)
ZA (1) ZA200109089B (xx)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040023948A1 (en) * 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
GB9910505D0 (en) * 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
EP1238675A1 (en) * 2001-03-06 2002-09-11 Fuji Photo Film B.V. Recombinant gelatin-like proteins for use as plasma expanders
ITRM20010380A1 (it) * 2001-07-02 2003-01-02 Bioprogress Spa Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
ATE303075T1 (de) * 2001-07-02 2005-09-15 Bioprogress Spa Teilhydrolysierte fischgelatine enthaltende zubereitungen und deren verwendung
KR100425226B1 (ko) * 2001-07-03 2004-03-30 주식회사 팜트리 아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
NZ535861A (en) * 2002-05-07 2006-11-30 Ferring Bv Desmopressin acetate in an orodispersible dosage form that disintegrates in the mouth within 10 seconds
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
UA93479C2 (xx) * 2002-11-26 2011-02-25 Альк-Абелло A/C Фармацевтичний алергенний препарат[фармацевтический аллергенный препарат
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
MXPA05009079A (es) 2003-02-28 2006-05-19 Alk Abello As Forma de dosificacion que tiene una matriz de sacarido.
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
EP2322198A2 (en) 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmaceutical compositions including low dosages of desmopressin
ES2260563T3 (es) 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
US9241902B2 (en) 2003-12-17 2016-01-26 R.P. Scherer Technologies, Llc Chewable soft capsules containing ungelatinized starch
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
EP1817009A2 (en) * 2004-11-24 2007-08-15 Spi Pharma, Inc. Orally disintegrating compositions
JP2008525420A (ja) * 2004-12-23 2008-07-17 マクニール−ピーピーシー・インコーポレーテツド 感覚的きっかけ剤を有する、口で崩壊する薬用組成物
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
GB0510286D0 (en) * 2005-05-19 2005-06-29 Kilda Biolink As Composition
KR101380147B1 (ko) * 2005-05-19 2014-04-04 아쿠아 바이오 테크놀로지 에이에스에이 젤라틴 함유 국소 조성물
TW200817049A (en) * 2006-06-05 2008-04-16 Verus Pharmaceuticals Inc Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
US20070293581A1 (en) * 2006-06-05 2007-12-20 Malcolm Hill Methods for Buccal, Lingual or Sublingual Dosing Regimens of Epinephrine for the Treatment of Allergic Emergencies
US20080014228A1 (en) * 2006-07-14 2008-01-17 Olivia Darmuzey Solid form
TWI343262B (en) * 2006-09-26 2011-06-11 Schering Corp Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist
MX2009005671A (es) * 2006-12-01 2009-06-08 Cima Labs Inc Forma de dosificacion de nicotina transmucosal oral.
US20090214442A1 (en) * 2006-12-01 2009-08-27 Cephalon, Inc. Oral Transmucosal Nicotine Dosage Form
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
CA2689434C (en) * 2007-06-04 2017-09-26 Shear/Kershman Laboratories, Inc. Tamper resistant lipid-based oral dosage form for opioid agonists
US20090004231A1 (en) * 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
KR100905027B1 (ko) * 2007-10-03 2009-06-30 (주)씨엘팜 식용 필름
GB2453770A (en) * 2007-10-19 2009-04-22 Reckitt Benckiser Healthcare Oral composition comprising a cooling agent
CN102036655B (zh) * 2008-02-28 2013-11-20 R·P·舍勒科技有限责任公司 使多晶型现象最小化的方法
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
TR201807224T4 (tr) 2008-05-21 2018-06-21 Ferring Bv Noktüri ile bozulmayan ilk uyku periyodunun arttırılması için ağızda dağılan desmopressin.
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US8420700B1 (en) * 2008-06-04 2013-04-16 James M. Bausch Tamper resistant lipid-based oral dosage form for sympathomimetic amines
ES2755029T3 (es) * 2008-08-05 2020-04-21 Wyeth Llc Liofilización por encima de la temperatura de colapso
JP2010143860A (ja) * 2008-12-19 2010-07-01 Chisso Corp タンパク質の安定化剤
TWI471127B (zh) 2009-04-29 2015-02-01 Intervet Int Bv 供人類使用之口服崩解錠劑的製備方法、所製得之口服崩解錠劑、以及含有該口服崩解錠劑的包裝物
PL3679941T3 (pl) 2009-06-18 2023-04-17 Serenity Pharmaceuticals Llc Bezpieczne podawanie desmopresyny
WO2011026080A1 (en) * 2009-08-31 2011-03-03 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam, processes for preparation, and use to treat arthritis and/or pain
US9775819B2 (en) * 2009-09-16 2017-10-03 R.P. Scherer Technologies, Llc Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
CN102933207B (zh) 2009-10-30 2018-02-02 Ix生物医药有限公司 快速溶解固体剂型
US10548839B2 (en) * 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
JO3112B1 (ar) * 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
MX350447B (es) 2010-03-29 2017-09-07 Ferring Bv Composicion farmaceutica de disolucion rapida.
BR112013009255B1 (pt) * 2010-10-08 2021-02-23 R.P. Scherer Technologies, Llc composição sólida de vacina oral de dissolução rápida
JP2012121850A (ja) * 2010-12-09 2012-06-28 Otsuka Pharmaceut Co Ltd アリピプラゾールの経口速溶性組成物
US8722636B2 (en) 2011-01-31 2014-05-13 New Market Pharmaceuticals, LLC Animal treatments
JP2011116764A (ja) * 2011-02-08 2011-06-16 Fine Seymour H 低用量デスモプレシンを含有する医薬組成物
BR112014005134A2 (pt) 2011-09-16 2017-04-18 Ferring Bv composição farmacêutica de dissolução rápida
EP3791866A1 (en) 2012-05-02 2021-03-17 NewMarket Pharmaceuticals LLC Pharmaceutical compositions for direct systemic introduction
TW201422254A (zh) 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
JP2015172084A (ja) * 2015-07-06 2015-10-01 大塚製薬株式会社 アリピプラゾールの経口速溶性組成物
CN107397208B (zh) * 2016-07-20 2021-05-07 吴登成 以鱼鳔胶为主成分的功能食品及其用途
JP7219712B2 (ja) * 2016-10-13 2023-02-08 キャタレント・ユーケー・スウィンドン・ザイディス・リミテッド 膣送達のための凍結乾燥医薬組成物
EP3532035B1 (en) * 2016-10-25 2023-06-07 Catalent U.K. Swindon Zydis Limited Compositions of different densities for fast disintegrating multi-layer tablet
ES2980126T3 (es) 2016-12-31 2024-09-30 Bioxcel Therapeutics Inc Uso de dexmedetomidina para el tratamiento de la agitación
KR20190104322A (ko) 2017-01-11 2019-09-09 훼링 비.브이. 속붕해성 약학적 조성물
DE102017104472A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung
US10517834B2 (en) * 2017-05-16 2019-12-31 Owen Murray Fast dissolving tablet formulations and methods of making thereof
WO2018237000A1 (en) * 2017-06-20 2018-12-27 Seattle Gummy Company PECTIN-BASED GEL COMPOSITION AND METHODS OF MAKING AND USING THE SAME
US20210023061A1 (en) 2017-11-12 2021-01-28 Biohaven Pharmaceutical Holding Company Ltd. Use of riluzole prodrugs to treat ataxias
US10988638B2 (en) 2018-03-08 2021-04-27 Catalent U.K. Swindon Zydis Limited Process to reduce endotoxin in gelatin
KR20200135465A (ko) * 2018-03-25 2020-12-02 바이오하벤 파마슈티컬 홀딩 컴퍼니 엘티디. Cgrp 관련 장애를 위한 리메게판트
JP2021525714A (ja) * 2018-05-27 2021-09-27 バイオヘイブン・ファーマシューティカル・ホールディング・カンパニー・リミテッドＢｉｏｈａｖｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｈｏｌｄｉｎｇ Ｃｏｍｐａｎｙ Ｌｔｄ． 疾患の処置のためのリルゾール口腔内崩壊錠の使用
JP7488201B2 (ja) 2018-06-27 2024-05-21 バイオエクセル セラピューティクス，インコーポレイテッド デクスメデトミジンを含むフィルム製剤、及びその作製方法
SG11202100880VA (en) 2018-08-16 2021-02-25 Biohaven Therapeutics Ltd Use of riluzole oral disintigrating tablets for treating diseases
PH12021551689A1 (en) * 2019-01-20 2022-05-11 Pfizer Ireland Pharmaceuticals Cgrp antagonists for treating migraine breakthrough
TW202045139A (zh) 2019-02-22 2020-12-16 英商康泰倫特英國斯文敦載迪斯有限公司 最小化線上混合期間之懸浮液之通氣
PH12021552022A1 (en) 2019-02-22 2022-09-12 Catalent Uk Swindon Zydis Ltd Preserving functionally-coated api particles produced by solventless mixing processes in aqueous suspension
WO2020169989A1 (en) 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
SG11202109022UA (en) 2019-02-22 2021-09-29 Catalent Uk Swindon Zydis Ltd Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
MX2022000709A (es) 2019-07-19 2022-05-19 Bioxcel Therapeutics Inc Regimenes de tratamiento con dexmedetomidina no sedante.
WO2021132741A1 (ko) * 2019-12-23 2021-07-01 주식회사 피엘마이크로메드 색전 시술 입자 및 이의 제조방법
AU2021317182A1 (en) 2020-07-31 2023-03-30 Catalent U.K. Swindon Zydis Limited Pharmaceutical compositions comprising coated API
CA3193124A1 (en) 2020-09-17 2022-03-24 Catalent U.K. Swindon Zydis Limited Use of surfactant with high molecular weight fish gelatin based dosage formulations to improve flow characteristics
CA3194494A1 (en) 2020-09-29 2022-04-07 Millicent Pharma Limited Orodispersible formulations
EP4243797A4 (en) * 2020-11-16 2024-11-13 Orcosa Inc. PLATFORM FOR RAPID INFUSION AND COMPOSITIONS FOR THERAPEUTIC TREATMENT IN HUMANS
US11672761B2 (en) * 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
US20240082340A1 (en) 2021-01-18 2024-03-14 Biohaven Therapeutics Ltd. Use of riluzole prodrugs to treat alzheimer's disease
WO2022179635A1 (zh) * 2021-02-27 2022-09-01 北京兴源联合医药科技有限公司 一种β-烟酰胺单核苷酸冻干口服制剂
KR20240075774A (ko) 2021-06-11 2024-05-29 오르파이 테라퓨틱스 인코포레이티드 안정화된 아필리모드 조성물 및 이의 용도
JP2024529727A (ja) * 2021-08-19 2024-08-08 マインド メディシン， インコーポレイテッド 治療適用のためのｄ－リゼルグ酸ジエチルアミドの凍結乾燥された口腔内崩壊錠製剤
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
WO2025034773A1 (en) * 2023-08-07 2025-02-13 Biohaven Therapeutics Ltd. Trpm3 modulators for treatment of pain

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
DE2556561C2 (de) 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4139497A (en) * 1977-04-04 1979-02-13 The Dow Chemical Company Dehydrogenation catalyst tablet and method for making same
US4762719A (en) * 1986-08-07 1988-08-09 Mark Forester Powder filled cough product
US5035896A (en) * 1988-06-15 1991-07-30 Warner-Lambert Company Water insoluble drugs coated by coacervated fish gelatin
MC2034A1 (fr) * 1988-06-23 1990-05-30 Hoffmann La Roche Preparations
IL87344A (en) 1988-08-04 1992-03-29 Univ Bar Ilan Process for the production of gelatin from fish skins
US4935243A (en) 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US4946684A (en) 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
EP0494972B1 (en) 1989-10-02 1996-11-27 Cima Labs, Inc. Effervescent dosage form and method of administering same
JPH06500632A (ja) 1990-08-10 1994-01-20 アナリティカル・コントロール・システムズ・インコーポレーテッド 改良された診断および治療組成物
FR2679451B1 (fr) 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
EP0609265B1 (en) * 1991-10-11 1997-05-28 Abbott Laboratories Unit-of-use reagent composition for specific binding assays
NZ246091A (en) 1991-12-24 1995-08-28 Yamanouchi Pharma Co Ltd Intrabuccally disintegrating preparation containing an active ingredient, agar, and lactose and/or mannitol
DE69216642T2 (de) 1992-01-13 1997-05-07 Pfizer Verfahren zur herstellung von tabletten mit hoher festigkeit
US5298261A (en) 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
FR2702968B1 (fr) 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
DE69429119T2 (de) * 1993-07-09 2002-07-18 R.P. Scherer Corp., Troy Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen
US5382437A (en) 1993-10-25 1995-01-17 Hunter Research Corporation Frozen liquified gas composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US5484888A (en) 1994-03-08 1996-01-16 Holzer; David Gelatin production
US5603952A (en) 1994-12-30 1997-02-18 Tastemaker Method of encapsulating food or flavor particles using warm water fish gelatin, and capsules produced therefrom
GB9517062D0 (en) 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
AU2636797A (en) 1996-04-16 1997-11-07 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
US5879796A (en) * 1996-09-05 1999-03-09 E. I. Du Pont De Nemours And Company Organic/inorganic particulates
US6071963A (en) * 1996-11-06 2000-06-06 Roche Vitamins Inc. Water dispersible compositions
ID24487A (id) * 1997-04-03 2000-07-20 Bridge Pharma Inc Senyawa-senyawa benzosikloheptatiofen
FR2766089B1 (fr) 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US6077540A (en) 1997-08-08 2000-06-20 Bayer Corporation Gelatin spray coating
US6020003A (en) * 1998-02-23 2000-02-01 Basf Corporation Method of making spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
US7972621B2 (en) 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight

Also Published As

Publication number Publication date
IL145783A (en) 2006-10-31
IS2403B (is) 2008-09-15
KR20020000160A (ko) 2002-01-04
CZ295324B6 (cs) 2005-07-13
EP1165053A4 (en) 2002-06-12
US6709669B1 (en) 2004-03-23
IL145783A0 (en) 2002-07-25
BR0009609A (pt) 2002-02-13
PL196572B1 (pl) 2008-01-31
EP1165053B1 (en) 2004-03-31
NZ515230A (en) 2004-01-30
KR100767076B1 (ko) 2007-10-17
EP1165053A1 (en) 2002-01-02
DK1165053T3 (da) 2004-06-01
CN1224381C (zh) 2005-10-26
DE60009472T2 (de) 2004-12-23
HU229892B1 (en) 2014-11-28
RO122011B1 (ro) 2008-11-28
NO20014859L (no) 2001-11-19
JP4838939B2 (ja) 2011-12-14
HK1039066A1 (en) 2002-04-12
PT1165053E (pt) 2004-06-30
JP2003524622A (ja) 2003-08-19
NO330196B1 (no) 2011-03-07
CA2369715C (en) 2006-03-21
HUP0201877A2 (hu) 2002-11-28
ATE262890T1 (de) 2004-04-15
CN1350450A (zh) 2002-05-22
AU761439B2 (en) 2003-06-05
PL354958A1 (en) 2004-03-22
DE60009472D1 (de) 2004-05-06
US9192580B2 (en) 2015-11-24
RU2242969C2 (ru) 2004-12-27
TR200102881T2 (tr) 2002-05-21
IS6102A (is) 2001-10-04
WO2000061117A1 (en) 2000-10-19
MXPA01010094A (es) 2002-05-06
GB9908014D0 (en) 1999-06-02
CZ20013588A3 (cs) 2002-06-12
CA2369715A1 (en) 2000-10-19
US20040076666A1 (en) 2004-04-22
AU4333100A (en) 2000-11-14
HK1039066B (zh) 2004-08-13
HUP0201877A3 (en) 2004-05-28
ES2215645T3 (es) 2004-10-16
NO20014859D0 (no) 2001-10-05

Similar Documents

Publication Publication Date Title
HK1039066A1 (en) Fast-dispersing dosage forms containing fish gelatin
YU33099A (sh) Farmaceutska smesa za poboljšanje erektilne disfunkcije kod muškaraca
TWI235068B (en) Sustained-release pharmaceutical composition
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
ATE340563T1 (de) DOSIERUNGSFORM DES TYPS ßHÜLLE UND KERNß MIT EINER WIRKSTOFFFREISETZUNG, DIE SICH DER NULLTEN ORDNUNG ANNÄHERT
DE69940674D1 (de) Orale verabreichung von adenosin analogen
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
SE9700885D0 (sv) New pharmaceutical formulation
ES2130081A1 (es) Comprimido de maleato de trimebutina con recubrimiento laminar.
TW200505436A (en) Modified release pharmaceutical compositions and the processes for preparing them
SG145717A1 (en) Composition for releasing a weak base for an extended period of time
AP1736A (en) Oral dosage form for controlled drug release.
EE03954B1 (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod
MX9606041A (es) Forma de dosificacion de rapida disolucion.